Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > The latest press Release

<< Previous

Bullboard Posts

Next >>

Comment by Gorf79on Jul 26, 2022 10:32am

191 Views

Post# 34850866

RE:RE:RE:RE:RE: The latest press Release

MM-

Thanks, I missed that "confirmed" but not disclosed detail
in the AGM deck. I thought that they were still negotiating with this partner. Looks like 6 sites handling an average of 4-6 patients each. I wonder who that could be???

I think I may know the un-named participant.

Easy enough to find out with a few phone calls, although I wouldn't post it here...

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"